MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Erasca, Inc. - Common Stock (NQ:ERAS)

6.760 +0.950 (+16.35%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,786,303
Open 6.070
Bid (Size) 6.910 (1,000)
Ask (Size) 6.950 (1,500)
Prev. Close 5.810
Today's Range 5.730 - 6.850
52wk Range 1.010 - 6.850
Shares Outstanding 151,043,118
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Get insights into the top gainers and losers of Thursday's after-hours session. ↗
Via Chartmill
News headline image
The $20 Billion Question: Revolution Medicines Surges as Big Pharma Circles the Pan-RAS Leader
The first week of 2026 has set the biotech sector ablaze, with Revolution Medicines (NASDAQ: RVMD) finding itself at the epicenter of a high-stakes acquisition tug-of-war. Shares of the Redwood... 
Via MarketMinute
Topics Intellectual Property

Performance

YTD
+88.3%
+88.3%
1 Month
+104.8%
+104.8%
3 Month
+175.9%
+175.9%
6 Month
+344.7%
+344.7%
1 Year
+145.8%
+145.8%

More News

Read More
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
Via Chartmill
News headline image
ERAS Stock Earnings: Erasca Misses EPS for Q2 2024 ↗
Via InvestorPlace
News headline image
ERAS Stock Earnings: Erasca Misses EPS for Q1 2024 ↗
Via InvestorPlace
News headline image
ERAS Stock Earnings: Erasca Beats EPS for Q4 2023 ↗
Via InvestorPlace
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
Targeted Cancer Therapies Gain Momentum as Precision Market Surges Past $106B
Via FinancialNewsMedia
News headline image
Targeted Cancer Therapies Gain Momentum as Precision Market Surges Past $106B
From FN Media Group LLC
Via GlobeNewswire
News headline image
Fidus Investment, Rocket Companies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
Why Concorde International Group Shares Are Trading Higher By 55%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
This Accenture Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday ↗
Via Benzinga
News headline image
Erasca Narrows Loss 46% in Fiscal Q2 ↗
Via The Motley Fool
News headline image
Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday ↗
Via Benzinga
News headline image
This Spotify Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗
Via Benzinga
News headline image
Stellantis, PG&E And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
Via Benzinga
News headline image
e.l.f. Beauty Posts Upbeat Earnings, Joins Nvidia, LiveRamp Holdings, Borr Drilling And Other Big Stocks Moving Higher On Thursday ↗
Via Benzinga
News headline image
$1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying ↗
Via Benzinga
News headline image
DXC Technology Issues Weak Outlook, Joins Take-Two Interactive And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
Erasca Reports First Quarter 2024 Business Updates and Financial Results
From Erasca, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
Erasca Announces $45 Million Oversubscribed Private Placement Financing
From Erasca, Inc.
Via GlobeNewswire
News headline image
Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results
From Erasca, Inc.
Via GlobeNewswire
News headline image
Erasca Announces Two Clinical Trial Collaboration and Supply Agreements for Trametinib to Evaluate Naporafenib Combination in SEACRAFT-1 and SEACRAFT-2 Trials
From Erasca, Inc.
Via GlobeNewswire
News headline image
Erasca to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
From Erasca, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Erasca, Inc. - Common Stock publicly traded?
Yes, Erasca, Inc. - Common Stock is publicly traded.
What exchange does Erasca, Inc. - Common Stock trade on?
Erasca, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Erasca, Inc. - Common Stock?
The ticker symbol for Erasca, Inc. - Common Stock is ERAS on the Nasdaq Stock Market
What is the current price of Erasca, Inc. - Common Stock?
The current price of Erasca, Inc. - Common Stock is 6.760
When was Erasca, Inc. - Common Stock last traded?
The last trade of Erasca, Inc. - Common Stock was at 01/09/26 04:00 PM ET
What is the market capitalization of Erasca, Inc. - Common Stock?
The market capitalization of Erasca, Inc. - Common Stock is 1.02B
How many shares of Erasca, Inc. - Common Stock are outstanding?
Erasca, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story